Granite FO LLC’s Novartis NVS Stock Holding History

Granite FO LLC’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Hold	14	–	–	﹤0.01%	139
2026 Q1	$2.14K	Hold	14	–	–	﹤0.01%	141
2025 Q4	$1.93K	Hold	14	–	–	﹤0.01%	154
2025 Q3	$1.79K	Hold	14	–	–	﹤0.01%	168
2025 Q2	$1.69K	Hold	14	–	–	﹤0.01%	169
2025 Q1	$1.56K	Hold	14	–	–	﹤0.01%	168
2024 Q4	$1.36K	Hold	14	–	–	﹤0.01%	174
2024 Q3	$1.61K	Buy	+14	New	+$1.59K	﹤0.01%	168
2024 Q2	–	Sell	-14	Closed	-$1.68K	–	151
2024 Q1	$1.68K	Buy	+14	New	+$1.44K	﹤0.01%	181

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Granite FO LLC's NVS Position: Q2 2026 in Review

Granite FO LLC held its Novartis (NVS) position steady in Q2 2026 at 14 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #139.

Granite FO LLC first reported a position in NVS in Q1 2024 and has held it in 9 quarters since. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Granite FO LLC held 14 shares of Novartis worth $2.19K as of Q2 2026.
Granite FO LLC left its Novartis share count unchanged in Q2 2026.
Novartis made up ﹤0.01% of Granite FO LLC's portfolio in Q2 2026, its #139 holding.
Granite FO LLC first reported a position in Novartis in Q1 2024 and has held it in 9 quarters since.
1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Granite FO LLC's 13F filing for Q2 2026, filed 15 Jul 2026.